Skip to main content

Iran's supreme leader gets jab of Iranian-made COVID-19 vaccine

Iran’s Supreme Leader Ayatollah Ali Khamenei said he turned down foreign-made vaccines because receiving Iran's own vaccine is a source of "national honor."
ATTA KENARE/AFP via Getty Images

Iran’s supreme leader received the country’s first domestically made coronavirus vaccine on Friday, describing the jab as a source of national pride.

“I did not want to use the non-Iranian vaccine,” state news outlets quoted the 82-year-old Ayatollah Ali Khamenei as saying. “So I said I would wait for the Iranian vaccine because we must respect this national honor.” 

Iran began human trials of the COVIran Barekat vaccine in late December, and last week, Iran gave emergency authorization to the vaccine developed by Iranian pharmaceutical company Shifafarmed. Scientists at Iran’s Pasteur Institute are also conducting clinical trials of the Cuban-made Soberana 2 vaccine.  

The Health Ministry said on Friday that by the end of August, vulnerable groups, ill patients and people over the age of 60 will be eligible to receive the Iranian vaccine, followed by students and teachers. 

In January, Khamenei announced he was banning the importation of vaccines made in the United States or United Kingdom, calling them unreliable. Iran’s leaders, meanwhile, have said US economic sanctions and banking restrictions have hindered their ability to secure vaccines from abroad. 

The World Health Organization’s COVAX initiative, however, has supplied Iran with vaccines from Russia, China and India. The Associated Press reports that through its participation in COVAX, Iran could import enough doses to inoculate half of its population.

Iran’s Health Ministry registered 115 more deaths from the virus on Friday, bringing the death toll to more than 83,500. The country of 83 million people has experienced the Middle East’s worst coronavirus outbreak, with more than 3.1 million cases. 

Iran’s new president-elect, hard-line judicial chief Ebrahim Raisi, has pledged to speed up the country’s vaccination drive when he takes office in August.

"Domestically produced vaccines and if necessary those produced abroad [will be obtained] quickly … so that people will feel at ease and the economy will flourish," Raisi said on Tuesday. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Already a Member? Sign in

Free

The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.

Free

What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing
Expert

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial
What's included:
Our Expertise

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

We also offer team plans. Please send an email to pro.support@al-monitor.com and we'll onboard your team.

Already a Member? Sign in